Biotech · Private company

Relypsa, Inc.

Track this companyFree. Adds Relypsa, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials80 recruiting or active

Pipeline programs3From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Pipeline3

Pragmatic Trial Of Alerts for Use of Mineralocorticoid Receptor AntagonistsNA · COMPLETED · started Nov 3, 2021ClinicalTrials.gov NCT04903717 · fetched Nov 12, 2026
Mineralocorticoid Receptor Antagonism Clinical Evaluation in Atherosclerosis Add-OnPHASE4 · TERMINATED · started Jul 17, 2018ClinicalTrials.gov NCT03597035 · fetched Nov 12, 2026
Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney DiseasePHASE2 · COMPLETED · started Jan 23, 2017ClinicalTrials.gov NCT03071263 · fetched Nov 12, 2026
An Intensive Lifestyle Intervention Program in CKD (Move to Health 2)NA · COMPLETED · started Jul 1, 2016ClinicalTrials.gov NCT02842957 · fetched Nov 12, 2026
Patiromer With or Without Food for the Treatment of HyperkalemiaPHASE4 · COMPLETED · started Feb 1, 2016ClinicalTrials.gov NCT02694744 · fetched Nov 12, 2026
A Two-Part, Single-Blind, Phase 3 Study Evaluating the Efficacy and Safety of Patiromer for the Treatment of Hyperkalemia (OPAL)PHASE3 · COMPLETED · started Feb 1, 2013ClinicalTrials.gov NCT01810939 · fetched Nov 12, 2026
Evaluation of Patiromer in Heart Failure PatientsPHASE2 · COMPLETED · started Apr 1, 2009ClinicalTrials.gov NCT00868439 · fetched Nov 12, 2026
An Open-Label, Multiple Dose Study to Evaluate the Pharmacology, Safety, and Tolerability of Patiromer in Participants on HemodialysisPHASE2 · TERMINATED · started Aug 1, 2008ClinicalTrials.gov NCT02033317 · fetched Nov 12, 2026